Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Verastem, Inc. (VSTM) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Verastem is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. The company is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt. VSTM has a research collaboration with Eisai Co., Ltd. for small molecule Wnt inhibitors. For more information, visit the company’s Web site: http://www.verastem.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *